Research Paper Volume 11, Issue 9 pp 2762—2786
MiR-191 inhibit angiogenesis after acute ischemic stroke targeting VEZF1
Figure 3. Cell apoptosis and cell cycle. (A, B) Cell apoptosis analysis of HUVECs transfected with miR-191 mimic (A) or miR-191 inhibitor (B)as assessed by flow cytometry; (C, D) Percentage of apoptosis HUVECs transfected with miR-191 mimic (C) or miR-191 inhibitor (D) (n =6 per group); (E, F) Cell cycle analysis of HUVECs transfected with miR-191 mimic (E) or miR-191 inhibitor (F) as assessed by flow cytometry; (G, H) Percentage of HUVECs transfected with miR-191 mimic (G) or miR-191 inhibitor (H) in different stages (n=6 per group). Means ± SEM.,** P< 0.01 vs. NCm or NCi.